Yujin Wang - Concepedia

Author

Yujin Wang

Huazhong University of Science and Technology ORCID

Also Known As

Wang Yujin, Y. Wang, YU-JIN WANG, Ya-xing Wang, Yu-jin Wang, Yujin Wang

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Huazhong University of Science and Technology Tongji Hospital Gilead Sciences (United States)Union Hospital Chinese Academy of Sciences

About

Yujin Wang is an author at Huazhong University of Science and Technology specializing in medicine, hepatitis, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	339
2	Engineering	2	2	26
3	Health Sciences	1	1	13
4	Management	1	1	24
5	Natural Sciences	1	1	200

Yujin Wang

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China Yueying Pan, Hanxiong Guan, Shuchang Zhou, European Radiology	2020	1K
CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China Shuchang Zhou, Yujin Wang, Tingting Zhu, American Journal of Roentgenology	2020	782
Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer Lianhong Xu, Hongtao Liu, Bernard P. Murray, ACS Medicinal Chemistry Letters Human Cyp3aPharmacotherapyAntiviral DrugChemical BiologyPharmaceutical Chemistry	2010	200
Damaged lung gas exchange function of discharged COVID-19 patients detected by hyperpolarized <sup>129</sup> Xe MRI Haidong Li, Xiuchao Zhao, Yujin Wang, Science Advances	2020	142
A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19) Tingting Zhu, Yujin Wang, Shuchang Zhou, Journal of Thoracic Imaging	2020	106
Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi® James G. Taylor, Sheila Zipfel, Kyla Ramey, Bioorganic & Medicinal Chemistry Letters Molecular VirologyViral HepatitisImmunologyAntiviral Drug DevelopmentHepatitis	2019	83
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa® John O. Link, James G. Taylor, Alejandra Trejo‐Martin, Bioorganic & Medicinal Chemistry Letters MedicineAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirology	2019	31
TERN-501, a potent and selective agonist of thyroid hormone receptor beta, strongly reduces histological features and biomarkers of non-alcoholic steatohepatitis associated pathology in rodent models Thorsten Kirschberg, Christopher Jones, Yingzi Xu, Journal of Hepatology	2020	31
Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway Xiaowei Wu, Minjie Li, Ying Li, Journal of Translational Medicine	2021	28
A prediction model of outcome of SARS-CoV-2 pneumonia based on laboratory findings Gang Wu, Shuchang Zhou, Yujin Wang, Scientific Reports	2020	27

Page 1